Bayer Intellectual Property GMBH et al v. Ascent Pharmaceuticals Inc. et al
| Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Intellectual Property GMBH and Bayer Pharma AG |
| Hetero Labs Limited and Ascent Pharmaceuticals Inc. |
| 1:2024cv00588 |
| May 16, 2024 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 11, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ascent Pharmaceuticals Inc.. (Hitch, Cortlan) |
| Filing 11 ANSWER to #1 Complaint, by Ascent Pharmaceuticals Inc..(Hitch, Cortlan) |
| Filing 10 STIPULATION to Extend Time to respond to the Complaint to August 12, 2024 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/10/2024 (nms). |
SO ORDERED, re #10 STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 8/12/2024). Signed by Judge Richard G. Andrews on 7/10/2024. (nms)
|
| Filing 9 SUMMONS Returned Executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG.Hetero Labs Limited served on 6/20/2024, answer due 7/11/2024. (Fahnestock, Derek) |
| Filing 8 SUMMONS Returned Executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG.Ascent Pharmaceuticals Inc. served on 6/20/2024, answer due 7/11/2024. (Fahnestock, Derek) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Remark: The MDL Panel has been notified. (nmg) |
| Filing 7 Summonses Issued as to Ascent Pharmaceuticals Inc. and Hetero Labs Limited on 5/16/2024. (Attachments: #1 Notice of Right to Sue Hetero Labs Limited)(jfm) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH, Bayer Pharma AG filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than April 2, 2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: No earlier than 10/2/2026. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Ascent Pharmaceuticals Inc., Hetero Labs Limited (Filing fee $ 405, receipt number ADEDC-4408832.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
